---
schema_version: "secwatch.filing_event.v1"
accession: "0000914475-24-000206"
form_type: "8-K"
ticker: "NBIX"
cik: "0000914475"
company_name: "NEUROCRINE BIOSCIENCES INC"
filed_at: "2024-10-11T23:59:59+00:00"
generated_at: "2026-05-30T16:11:10.874602+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Neurocrine appoints Kyle Gano as CEO effective Oct 11, 2024; base salary $900k

## Summary
- Kyle Gano, Ph.D. named President and CEO effective October 11, 2024, under an amended employment agreement.
- Annual base salary of $900,000; target cash bonus of 100% of base salary.
- Promotion equity grants: $750k stock options, $300k RSUs, $450k PRSUs (total $1.5M).
- Severance includes 1.5x salary plus bonus for non-CIC termination; 2x for CIC termination with full vesting.

## SEC filing metadata
- accession: 0000914475-24-000206
- form_type: 8-K
- ticker: NBIX
- cik: 0000914475
- company_name: NEUROCRINE BIOSCIENCES INC
- filed_at: 2024-10-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/914475/000091447524000206/0000914475-24-000206-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/914475/000091447524000206/nbix-20241011.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000914475-24-000206
- JSON: https://secwatch.observer/filing/0000914475-24-000206.json
- Plain text: https://secwatch.observer/filing/0000914475-24-000206.txt

## Key facts
- Executive change
  Kyle Gano was appointed as President and Chief Executive Officer at NEUROCRINE BIOSCIENCES INC.
  - Action: appointed
  - Role: President and Chief Executive Officer
  source text: Pursuant to the Employment Agreement, Dr. Gano will serve as Neurocrine Biosciences’ President and Chief Executive Officer effective October 11, 2024 (the “Effective Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/914475/000091447524000206/0000914475-24-000206-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.